Oncolytics Biotech schedules FDA meeting on anal cancer drug pathway

April 6, 2026 9:00 AM

Oncolytics Biotech Inc. (NASDAQ: ONCY) announced it has scheduled a Type C meeting with the U.S. Food and Drug Administration ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found